Radical Technologies

Radical Technologies (also known as Radical Catheter Technologies) is a medical device company and commercialization partner specializing in neurovascular access and delivery solutions. A portfolio company of NeuroTechnology Investors (NTI), the firm utilizes its proprietary "Radical Catheter" platform, which employs a unique ribbon-based design to provide simultaneous flexibility, pushability, and stability in tortuous anatomy. Beyond its own catheter portfolio, Radical Technologies operates a specialized neurovascular commercialization team that partners with other NTI companies, such as Serenity Medical, to launch breakthrough technologies like the FDA-approved River™ stent for idiopathic intracranial hypertension. The company is headquartered in Mountain View, California, and is led by industry veterans Martin Dieck and Brian Martin.